Jorge Conde

speaker

469 appearances 4 recordings 1 series first heard Sep 2025 last heard 2 Sep

Jorge Conde’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 2 in all, peaking in Sep 2026 with 1.

Appearances

newest first · ▶ plays the moment

The a16z Show · Inside Moderna’s Personalized Cancer Vaccine · 2 Sep 2026 podcast

And at um at scale, um how many roughly how many for let's sit let's just focus on melanoma, how many uh doses would you need to produce in a given year?

Yeah, I I can believe that.

Um ha have you disclosed how you think about cogs and price or is that something that

So maybe one place to focus is uh on this concept of personalization.

Uh I'm sure you've seen uh the story of the of the GitLab founder uh who went founder mode on his on his own uh osteosarcoma.

Um uh number one, uh

Do the future cids of the world um come to Moderna or is is this end of one phenomena something that you think will just happen and exist in parallel?

And in that world, um, how does the how does the regulatory environ uh the regulatory apparatus function here?

So in other words, you you mentioned earlier uh you along with Mark will prepare um uh a regulatory filing soon.

Um what gets regulated here?

Because every dose is different, so obviously every dose doesn't get approved.

Is it is it obviously the the the process for synthesizing mRNA?

Is it the algorithm?

Is it a combination of the entire system?

Help us uh understand that and build intuition around how we think.

that these kinds of personalized medicines will be regulated in the future.

How do we think about uh moving beyond or how do you all think about moving beyond melanoma?

Uh is this an approach that's going to be uh applicable to a broad range of cancers?

Are there cancers that are much more likely where this is going to be a viable uh option versus others?

Showing 81–100 of 469 · page 5 of 24